Krebs Biochemicals and Industries Limited — Board Meeting, 20-05-2025: Outcome of Board Meeting

Krebs Biochemicals & Industries has announced a board meeting on the financial results for the quarter and half-year. The company reported total income of Rs. 44.02 Cr for FY25, down from Rs. 50.87 Cr last year. Expenses increased slightly to Rs. 70.94 Cr, resulting in a loss before tax of Rs. 26.92 Cr versus Rs. 19.73 Cr previously. EPS slipped to -Rs. 12.49 from -Rs. 9.15, while net worth remained deeply negative at -Rs. 146.24 Cr. The audit was clean, but cash flow continues to show operating cash burn.